Does hepatic insulin resistance raise blood glucose and mildly elevate ALT?

The claim describes two closely linked, well-established features of metabolic liver dysfunction: impaired control of hepatic glucose output and possible low-grade hepatocellular injury.

Clinical and metabolic evidence

• Human stable-isotope tracer hyperinsulinemic–euglycemic clamp studies show that hepatic insulin resistance causes a right-shifted insulin response: higher insulin concentrations are needed to suppress endogenous glucose production, and suppression may remain incomplete in type 2 diabetes.
• The defect involves inadequate suppression of both gluconeogenesis and glycogenolysis. Consequently, excess liver-derived glucose enters the circulation and contributes to fasting and post-meal hyperglycemia.
• This is an important contributor rather than the sole determinant of glycemia; peripheral glucose disposal, food intake, medications, and other metabolic factors also influence blood glucose.
• In biopsy-characterized metabolic liver disease, fasting glucose production increases with MASH activity and fibrosis independently of diabetes status, suggesting that more active or fibrotic liver disease can be associated with greater hepatic glucose output.

Liver injury and ALT

• Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause mild ALT elevation through hepatic lipid accumulation, lipotoxicity, mitochondrial dysfunction, oxidative stress, inflammation, and hepatocyte injury.
• ALT is a marker of hepatocellular injury, not a measure of steatosis, steatohepatitis activity, or fibrosis stage. AASLD guidance considers ALT above 30 U/L generally abnormal; suggested true-normal ranges are approximately 29–33 U/L in men.
• Normal ALT does not exclude meaningful MASLD/MASH or fibrosis: more than two-thirds of affected individuals may have normal aminotransferases at a given time. Conversely, mild ALT elevation is nonspecific and warrants consideration of other causes and structured fibrosis-risk assessment.

Bottom line

• Hepatic insulin resistance plausibly and directly contributes to elevated glucose by failing to restrain liver glucose production; metabolic liver stress can also produce mild ALT elevation, but ALT alone cannot diagnose or stage metabolic liver disease.